chartexchange

ZVRA
Zevra Therapeutics, Inc. Common Stock
stockNASDAQ

At CloseOct 2, 2026 4:00:01 PM EDT
9.99USD-1.866%(-0.19)951,870
Pre-marketOct 2, 2026 9:14:30 AM EDT
10.29USD+1.081%(+0.11)
Loading…
Loading…
593.61M
Healthcare
Biotechnology
HQ
Celebration, FL, USA
Previous Close
$10.18
Beta
0.83
52-Week High
$15.04 2026-07-08
52-Week Low
$8.01 2025-12-19
SMA 50
$11.33
SMA 200
$10.56
Avg. Vol 10D
949,437
Avg. Vol 30D
915,089
Avg. Vol 90D
1.40M
Relative Vol
1.04
54.93M
0.3200%
1,000,000
19,240
Nov 4, 2026 (30d)
ZVRA Profile

kempharm is a biopharmaceutical company focused on the discovery and development of new chemical entities (nces) to treat serious medical conditions through its proprietary and broadly applicable ligand activated therapy (lat) approach. the company utilizes its lat technology to generate improved prodrug versions of fda approved drugs in the high needs areas of pain, adhd and other cns diseases.

ZVRA Performance
PeriodPriceDateChangeBeta
1W11.302026-09-28-11.54%-0.816
1M12.402026-09-04-19.39%-0.045
3M13.972026-07-06-28.45%0.126
6M9.742026-04-06+2.63%0.748
1Y10.652025-10-06-6.14%0.833
2Y7.202024-10-04+38.84%—
5Y5.332023-03-02+87.55%0.358
ZVRA Stock Summary

Zevra Therapeutics, Inc. Common Stock (NASDAQ:ZVRA) stock price today is $10.00, and today's volume is 951,870. ZVRA is down 1.806% today. The 30 day average volume is 915,089. ZVRA market cap is $593.61M with 59.38M shares outstanding.